Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen Cataplasm for Knee Osteoarthritis Pain
CTR20244742Phase 3Terminated
- Sponsor
- Sunshine Novo
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen in knee osteoarthritis (OA), osteoarthritis (OA), Periarthritis humeroscapularis, tendinitis, tendovaginitis, sponsored by Sunshine Novo. Started Dec 2024; status: terminated.
02
Drugs
flurbiprofen
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)Periarthritis humeroscapularistendinitistendovaginitis
Beyond the preview
Go deeper on CTR20244742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244742.